20
Participants
Start Date
November 1, 2022
Primary Completion Date
December 1, 2025
Study Completion Date
June 1, 2026
CRT
50 Gy in 2 Gy fractions over 25 working days + capecitabine 1650 mg/m2/d PO
SCPRT
25 Gy in 5 Gy fractions over 5 working days
CROSS Protocol
41.4 Gy in 1.8 Gy fractions over 23 working days + carboplatin AUC of 2 mg/ml/min + paclitaxel 50 mg/m2 IV Q1W
PD-L1 PET
10 mg atezolizumab IV followed by 37 MBq 89Zr-atezolizumab IV. PET imaging will be done before neoadjuvant CRT/SCPRT (day 0) and between day 10-14 during CRT/SCPRT.
RECRUITING
Medical University of Vienna, Vienna
Johannes Laengle, MD, PhD
OTHER